CENERX BIOPHARMA INC has a total of 18 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Chile. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GUDMUNDSSON KRISTJAN, PIRAMED LTD and SOLVEJ FARMAS JUTIKALS B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 2 | |
#3 | Chile | 2 | |
#4 | Israel | 2 | |
#5 | Taiwan | 2 | |
#6 | United States | 2 | |
#7 | Australia | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Rafferty Michael | 9 |
#2 | Haney Brian P | 4 |
#3 | Isbester Paul K | 4 |
#4 | Palmer Grant J | 4 |
#5 | Brot Elisabeth C A | 4 |
#6 | Metcalfe Nigel | 4 |
#7 | Keefe Daniel K Jr | 2 |
#8 | Keshtmand Majid | 1 |
#9 | Free James Cecil | 1 |
#10 | Krishnan Ranga | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011096953A1 | Oral antidepressant formulation with reduced excipient load | |
WO2008141112A1 | Methods of treating rett syndrome | |
AU2007325686A1 | Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders | |
US2008009542A1 | Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide |